News Release

US Pharmacopeia partners with Quantros to enhance the MEDMARX patient safety reporting program

MEDMARX to become the world's largest known database of medication errors

Business Announcement

US Pharmacopeia

Rockville, Md., December 6, 2007 — The U.S. Pharmacopeia (USP) has formed a strategic alliance with Quantros, a health care information management technology provider, to enhance MEDMARX, USP’s premier adverse drug event reporting program. The more robust database resulting from this alliance will provide USP and users of MEDMARX access to larger data sets from more U.S. hospitals and health systems for the identification and prevention of medication errors and adverse drug events. The MEDMARX database currently draws from more than 400 hospitals and healthcare systems and is the largest medication error database in the world.

Under this arrangement, Quantros will manage the operations of the MEDMARX system, including marketing, sales and client support. This will enable USP to continue its focus, even more intently, on data analysis, research, standards-setting and dissemination of safe practices that will help practitioners prevent errors.

“Quantros’ and USP’s patient safety efforts are complementary,” said Roger L. Williams, M.D., executive vice president and CEO of USP. “The two organizations share a commitment to reducing medication errors and improving public health. This partnership will provide customers with the best of each organization’s strengths—clinical technology management from Quantros, and data analysis, research, standards-setting and reporting from USP.”

“We look forward to providing MEDMARX subscribers with an even more robust database that can reveal to health care providers additional valuable patient safety information,” said Sanjaya Kumar, M.D., president and CEO of Quantros.

The USP/Quantros partnership takes effect Jan. 1, 2008.

###

USP—Advancing Public Health Since 1820

The United States Pharmacopeia (USP) is a private, non-profit, standards-setting organization that advances public health by ensuring the quality and consistency of medicines, promoting the safe and proper use of medications, and verifying ingredients in dietary supplements. These standards, which are recognized worldwide, are developed by a unique process of public involvement through the contributions of volunteers representing pharmacy, medicine, and other health care professions, as well as science, academia, government, the pharmaceutical industry, and consumer organizations. For more information about USP and its four public health programs, visit www.usp.org/newscenter. FY0819

About Quantros

Quantros provides real-time actionable knowledge creation solutions for benchmarking, patient safety, accreditation and compliance, and outcomes monitoring for leading healthcare providers, payers, and pharmaceutical manufacturers. For more information about Quantros, visit www.quantros.com.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.